Long-Term Assets: The sum of all assets classified as non-current.
Ensysce Biosciences, Inc. (ENSC) had Long-Term Assets of $0.21M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.88M |
|
$-2.77M |
|
-- |
|
$1.88M |
|
$4.66M |
|
$-2.78M |
|
$0.01M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.78M |
|
$-2.78M |
|
2.56M |
|
2.56M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$7.24M |
|
$0.12M |
|
|
Long-Term Assets |
$0.21M |
$7.45M |
|
$4.57M |
|
-- |
|
-- |
|
$4.57M |
|
$2.88M |
|
$2.88M |
|
$2.88M |
|
4.58M |
|
| Cash Flow Statement Financials | |
$-7.81M |
|
$-0.12M |
|
$8.74M |
|
$3.50M |
|
$4.31M |
|
$0.81M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.59 |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
100.00% |
|
-147.79% |
|
-147.79% |
|
-- |
|
-147.05% |
|
-147.03% |
|
$-7.93M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
-- |
|
4.48 |
|
20.10 |
|
-95.95% |
|
-95.95% |
|
-37.14% |
|
-95.95% |
|
$0.63 |
|
$-3.10 |
|
$-3.05 |
|